Major demyelinating diseases include multiple sclerosis (MS), neuromyelitis optica spectrum disorder (NMOSD), acute disseminated encephalomyelitis (ADEM) and myelin oligodendrocyte glycoprotein (MOG) encephalomyelitis. As treatment strategies differ among these diseases, precise diagnosis of demyelinating diseases is crucial, and magnetic resonance imaging (MRI) plays a pivotal role in the diagnosis. In the present review, MRI appearances of characteristic lesions of these demyelinating diseases, and differentiation between MS and other demyelinating diseases based on MRI findings are discussed.
Introduction
Multiple sclerosis (MS), neuromyelitis optica spectrum disorder (NMOSD), acute disseminated encephalomyelitis (ADEM) and myelin oligodendrocyte glycoprotein (MOG) encephalomyelitis are major inflammatory demyelinating diseases. The most important roles of magnetic resonance imaging (MRI) in demyelinating diseases include: (i) diagnosis; [1] [2] [3] [4] [5] (ii) imaging biomarkers; [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] and (iii) monitoring of sideeffects from disease-modifying drugs. [18] [19] [20] [21] The present review will focus on the diagnostic role of MRI in these diseases. Precise diagnosis of demyelinating diseases is crucial, because treatment strategies differ between pathologies and thus can greatly influence patient prognosis. 2, 3, [22] [23] [24] [25] [26] [27] In the present review, characteristic lesions of demyelinating diseases, and differentiation between MS and other demyelinating diseases are discussed.
Characteristic lesions of demyelinating diseases

MS
MRI plays a pivotal role in diagnosing MS. 2 Although diagnosis of MS cannot be made solely from MRI, an understanding of the characteristic MRI findings of MS lesions is important for precise diagnosis.
Ovoid lesions
These ovoid-shaped periventricular or deep white matter lesion are spread long in the direction perpendicular to the lateral ventricle wall (Fig. 1 ). This finding is considered to reflect inflammation around the long axis of the medullary veins (Dawson's finger). 1 Although this type of lesion is frequently (63%) seen in MS, 28 similar lesions can be seen in other diseases, such as NMOSD and ischemia, so the specificity of this type of lesion is not very high. Veins running through MS lesions (central vein sign) are frequently seen on T2*-weighted images, susceptibility-weighted images and fluid-attenuated inversion recovery (FLAIR) T2*-weighted images (combined T2*-weighted and FLAIR images), which could be useful for differentiation from diseases, such as NMOSD, cerebral small vessel disease, Susac syndrome, migraine and inflammatory vasculopathies (Behc ßet's disease, primary angitis of the central nervous system, antiphospholipid syndrome, Sj€ ogren's syndrome and systemic lupus erythematosus).
Callosal-septal interface lesions
These intracallosal lesions spread perpendicularly to the ventricular wall (Fig. 2) . 32, 33 This type of lesion is seen in more than half of MS patients. 28, 32 The corpus callosum is resistant to ischemia and can provide a point of differentiation from ischemic lesions. Both sensitivity and specificity are considered high for MS. As these findings are well depicted on thin sagittal FLAIR images, sagittal FLAIR imaging is included in the standard MRI sequences for diagnosing MS. 34 Callosal lesions are also seen in NMOSD and Susac syndrome, but are usually large in those diseases, which can help in differentiation from MS. 22, 35, 36 Isolated U-fiber lesions, juxtacortical lesions These MS lesions extend along the subcortical Ufibers. [37] [38] [39] They are considered to represent perivenous inflammation along the subcortical U-fibers (Fig. 3) . 37 Approximately half of MS patients have at least one isolated U-fiber lesion. 37 This type of lesion is relatively specific for MS, and has thus been adopted as an MRI criterion for demonstrating dissemination in space in the McDonald criteria. 2 Cortical lesions MS lesions involve not only cerebral white matter, but also gray matter, including the cortex (Fig. 4) . Double inversion recovery 40 and phase-sensitive inversion recovery 41 are sensitive sequences for detecting cortical lesions. Cortical lesions are rarely seen in NMOSD, migraine patients or healthy individuals, and are thus useful for differentiation from these diseases. 42 Cortical lesions have been added to the MRI criteria for dissemination in space in the 2017 McDonald criteria. ( Fig. 5) . 43 This hypointensity is considered to represent severe pathological changes, including axonal loss, 44 although acute lesions with significant edema can be temporally hypointense on T1-weighted images. 43 
Enhancing lesions
Active MS lesions might be enhanced after injection of gadolinium. 45 The sensitivity of gadolinium-enhanced MRI for detecting disease activity is 5-10-fold higher than that of clinical relapse, 12, 46 and contrast enhancement thus offers an index of ongoing disease activity. 6 Most enhancing lesions show a solid enhancement pattern. 47 Ring enhancement is also frequently seen, and the ring is often discontinuous (open-ring sign; Fig. 6 ). 47, 48 Enhancement of each lesion disappears within 6 months. 47 Brain atrophy Brain atrophy might be identified in the early stage of the disease, and becomes more prominent in the chronic stage. 49 Brain volume decreases at a rate of 0.5-1.6% per year in MS patients, 21, 50 but occurs at a rate of 0.1-0.3% in healthy controls. 21 Tissue loss of gray matter is considered more prominent than that of white matter. 49, 51 A temporal decrease in brain volume (pseudoatrophy) might be seen after administration of steroids, interferon beta and natalizumab. 21 A recent report stated that the speed of decrease in whole brain volume is slower in Japanese patients, 49 but another recent report stated that the speed of decrease in deep gray matte volume was faster in Japanese patients than in Caucasian patients. 52 Further studies with a larger number of patients might be required to clarify the details and mechanisms of brain atrophy processes in Japanese MS patients. Coronal gadolinium-enhanced image shows a periventricular ringenhancing lesion. Note that the enhancing ring is discontinuous (arrow).
Dirty-appearing white matter (diffusely abnormal white matter) Diffuse, subtle hyperintensities are sometimes identified in the periventricular or deep white matter on T2-weighted images (Fig. 7) . 28, [53] [54] [55] This type of lesions might represent mild axonal loss, myelin loss and gliosis. 54, 56 Tumefactive lesions These large (>2 cm) demyelinating lesions show a mass effect, edema and/or ring enhancement that mimic primary brain tumors, including high-grade glioma or lymphoma (Fig. 8) . 57, 58 Approximately 70% of patients with tumefactive lesions fulfill the McDonald criteria at follow up (median time to second attack: 4.8 years). 57 Tumefactive lesions can also be seen in patients with NMOSD, particularly in aquaporin-4 (AQP4)-seropositive patients, and in those with ADEM. 22, 59 Cases of tumefactive lesions in patients receiving disease-modifying drugs have also been reported. [60] [61] [62] [63] A variety of gadolinium-enhancing patterns, such as homogeneous, heterogeneous, patchy and diffuse, open-ring, and irregular rim, are seen according to different pathologies. 64 Tumefactive demyelinating lesions can be differentiated from tumors, such as glioblastoma or lymphoma, by the following points: (i) tumefactive lesions have less mass effect compared with tumors; 57 (ii) surrounding enhancement of tumefactive lesions is often discontinuous (open-ring sign); 64, 65 (iii) a T2-hypointense rim is seen in approximately half of tumefactive lesions; 66 (iv) perilesional edema is mild or absent in 57% of tumefactive lesions; 66 (v) relative cerebral blood volume on perfusion MRI is lower in tumefactive lesions than tumors; 67 (vi) density on non-contrast-enhanced computed tomography of MRI enhancing portions is lower in tumefactive lesions than in tumors; 68 (vii) intralesional susceptibility signals (dot-like hypointensities) are not seen in tumefactive lesions, although these signals are almost always seen in glioblastomas; 69 and (viii) a dilated vein coursing within the lesion might be seen. 70, 71 Tumefactive lesions usually diminish on follow-up MRI, in contrast to continual enlargement seen in real tumors. 45 Bal o's concentric sclerosis This is a rare variant in which white matter is destroyed in concentric layers. This used to be considered as a monophasic rapidly progressive and fatal disease, but an increasing number of cases with better outcomes have been reported. 72, 73 Bal o's concentric sclerosis has been reported in patients with NMOSD. 74, 75 A recent study showed that Bal o's concentric sclerosis might be immunologically distinct from MS, and could be similar to NMOSD or MOG encephalomyelitis. 76 Spinal cord lesions Spinal cord lesions are seen in up to 90% of MS patients. 45, 77 The cervical spinal cord is most frequently involved. 45 The lesions are typically well-circumscribed in the acute stage and often involve the periphery (Fig. 9) . 45, 77 The lesions are usually small and short, and longitudinally extensive transverse myelitis (LETM) extending three or more vertebral segment lengths is very rare in MS, in contrast to NMOSD, ADEM and MOG encephalomyelitis. 22, 28 Spinal cord atrophy is also frequently seen in the chronic stage. 45, 77 Optic nerve lesions In the acute stage, swelling of the optic nerve and enhancement of the optic sheath are frequently identified. 78 Dilatation of the subarachnoid space at the anterior end of the optic nerve might also be seen. 78 In the chronic stage, optic nerve atrophy might be seen. 77, 79 In MS, optic neuritis is typically unilateral and involves a shorter segment, with less extension to the optic chiasm. 22 Short-inversiontime recovery and fat-suppressed gadoliniumenhanced imaging are useful for observing optic nerve lesions in the intraorbital segments. 
NMOSD
Brain lesions are seen in 43-70% of patients with NMOSD at the disease onset, and the prevalence of brain lesions becomes more frequent with increasing duration of the disease. 26, 80 NMOSD patients with associated autoimmune disease show a relatively high frequency of brain lesions. 81 Brain lesions can be seen not only in areas with high AQP4 expression, but also in those without high AQP4 expression. 26 MRI is mandatory for diagnosing NMOSD. Dorsal brainstem lesions adjacent to the fourth ventricle including the area postrema This is one of the most characteristic MRI lesions of NMOSD, seen in 7-46% of patients. 3, 22, 26 Patients with this lesion often develop intractable hiccups, nausea and/or vomiting. The area postrema, as the location of the emetic reflex center, lacks a bloodbrain barrier, and is vulnerable to AQP4-immunoglobulin (Ig)G attack. This type of lesion is often contiguous with upper cervical cord lesions (Fig. 10) .
22,26
Diencephalic lesions surrounding the third ventricles and cerebral aqueduct Lesions involving the hypothalamus, thalamus and periaqueductal area of the midbrain. 22, 26 Patients with these lesions might present with symptoms related with hypothalamic/pituitary dysfunction, including hypothermia, hypotension, hypersomnia, obesity, narcolepsy, syndrome of inappropriate antidiuretic hormone secretion, hyperprolactinemia (amenorrhea, galactorrhea), hypothyroidism and behavioral changes. 26 Periependymal corpus callosal lesions Callosal lesions are seen in 12-40% of NMOSD patients. 26 Callosal lesions in NMOSD typically involve its ependymal surface, often affecting most of its length. 22 This differs from the "callosal-septal interface lesions" typically seen in MS. In the acute phase, callosal lesions might be edematous and heterogeneous (marbled pattern); 82 sometimes extensively involving the splenium (arch bridge pattern). 83 Lesions involving the corticospinal tract This is one of the most common MRI findings in NMOSD, found in 23-44% of patients (Fig. 11) . 26, 83 The corticospinal tracts are not regions where AQP4 is highly expressed, so why these regions are frequently involved in NMOSD remains unclear. 22 Hemispheric white matter lesions Extensive and confluent lesions involving the cerebral hemisphere are seen in 29% of NMOSD patients. 83 Lesions are often tumefactive, but mass effects are usually absent. 26 Extensive lesions are more frequently seen in AQP4 antibody seropositive patients than in seronegative patients. 26 Non-specific dot-like or patchy lesions are also seen in cerebral white matter at high frequency (35-84%; Fig. 12) . 26, 83 These lesions do not abut onto and are not perpendicular to the lateral ventricles, which can help distinguish from MS. 83 
Cortical lesions
Cortical lesions are usually considered as a "red flag" for the diagnosis of NMOSD, 22 but are rarely (3.1%) seen in AQP4-positive NMOSD. 84 Cortical lesions Figure 10 A dorsal brainstem lesion including the area postrema in neuromyelitis optica spectrum disorder. Sagittal T2-weighted short-inversion-time recovery image shows a lesion involving the dorsal medulla oblongata extending into the upper cervical spinal cord.
might involve the subpial layer, and leptomeningeal enhancement can be seen. 22, 84, 85 As described later, cortical lesions are more frequently seen in MOG encephalomyelitis.
Enhancing lesions
The enhancement pattern of brain lesions in NMOSD is variable; patchy and inhomogeneous with poorlydefined margins (cloud-like), periependymal linear patterns (pencil-thin enhancement), and leptomeningeal and nodular enhancements have been reported. 22, 26, 86, 87 Ring and open-ring enhancement are rare in NMOSD. 22 
Spinal cord lesions
The most typical spinal cord lesion is acute LETM (Fig. 13a) . 3, 22, 26, 88 However, non-longitudinally extensive myelitis is also often identified (Fig. 14) . 28 Upper thoracic cord involvement is most frequent. 28 The central gray matter is preferentially involved (Fig. 13b) . Bright spotty lesions on T2-weighted images corresponding to dark lesions on T1-weighted images are often identified, and might reflect necrotic and microcystic changes. 22 Cord swelling (Fig. 13a ) and gadolinium enhancement can be shown in the acute stage, and focal cord atrophy can be observed in the chronic stage (Fig. 15) . 22, 88 Optic nerve lesions In AQP4-positive NMOSD patients, optic nerve involvement with swelling and gadolinium enhancement is often identified. Optic nerve involvement might affect more than half of the length of the optic nerve (longitudinally extensive optic neuritis), predominantly affecting the posterior part and/or involving the optic chiasm, and optic tracts with bilateral visual disturbance can be seen. 22, 88 In the chronic stage, optic nerve atrophy with signal hyperintensity can be observed on T2-weighted images.
22,88
ADEM
Brain lesions Typical brain lesions in ADEM include bilateral, asymmetrical, poorly demarcated, large lesions involving supra-and infratentorial white matter (Fig. 16) . 4, 22, 59 The thalami and basal ganglia are also frequently involved.
22 T1 black holes are rare (5%). 89 Callosal lesions are sometimes seen, and are larger than in MS. 45 As ADEM is usually a monophasic disease, MRI should not show evidence of previous demyelinating lesions or evidence of more than one relapse. 45, 59 Follow-up MRI usually shows complete or near-complete lesion resolution. 90 Gadolinium enhancement is seen in up to 30% of patients. 59 Acute lesions might show enhancement, and these lesions enhance simultaneously. 45 
Figure 11
Corticospinal tract lesion in neuromyelitis optica spectrum disorder. Coronal T2-weighted short-inversion-time recovery image shows a lesion extending along the left corticospinal tract, including the internal capsule and cerebral peduncle (arrow).
Figure 12
Non-specific dot-like or patchy lesions in neuromyelitis optica spectrum disorder. Axial fluid-attenuated inversion recovery image shows multiple patchy lesions and tiny lesions.
Severe cases of ADEM might show petechial hemorrhage. In a more aggressive form of ADEM (i.e. acute hemorrhagic leukoencephalitis), lesions are larger with a greater mass effect and hemorrhages are seen. 45 Whether acute hemorrhagic leukoencephalitis is a variant of ADEM or separate entity remains controversial. 59 Spinal cord lesions Spinal cord lesions are seen in 11-28% of patients, and LETM is the typical spinal cord lesion, similar to that in NMOSD. 22, 59, 91 Gadolinium enhancement is variable. 91 The thoracic cord is most often involved.
91
Optic nerve lesions Patients with ADEM on rare occasions later develop optic neuritis, as "ADEM followed by optic neuritis". 59, 92 MOG-IgG is positive in most of these patients.
92-94
MOG encephalomyelitis (MOG-IgG disease)
MOG encephalomyelitis (MOG-IgG disease) was recently proposed as a new, distinct disease entity among the demyelinating diseases. 95, 96 This disorder presents with a variety of clinical phenotypes, and optic symptoms are the most frequent manifestation. It has been reported that 21-42% of AQP4-IgG-negative NMOSD patients are MOG-IgG-positive. [97] [98] [99] MOG-IgG positivity is found in patients who have previously been diagnosed with a variety of clinical phenotypes, such as ADEM, MS, optic neuritis and transverse myelitis.
92,98,100,101 A significant percentage of patients previously diagnosed with multiphasic demyelinating encephalomyelitis and ADEM followed by optic neuritis are also MOG-IgG-positive. 92, 94 MRI features of the brain, spinal cord and optic nerves in patients with MOG encephalomyelitis are distinct from those of AQP4-IgG-positive NMOSD and typical MS. 97, 102 Brain lesions Typically, lesions appear as a small number (≤3) of poorly demarcated infratentorial lesions, 103 and thalamic and pontine lesions are distinctive MRI findings. 104 Supratentorial deep white matter lesions can be seen (Fig. 17) . 102 Children tend to show a greater frequency of a higher number of lesions, bilateral lesions and larger lesions, especially in the deep gray matter and brainstem. 22, 103 Ovoid lesions are not usually seen. 27 Cortical lesions and leptomeningeal enhancement are seen in 16% and 6% of patients, respectively ( Fig. 18) . 104 Ogawa, et al. 105 reported cases presenting with unilateral cortical encephalitis with epileptic seizure. Wang et al. 106 reported that 21% of MOGIgG-positive patients presented with encephalitis, and one-third of these patients also showed anti-Nmethyl d-aspartase receptor antibody. MOG antibody-positive cortical encephalitis might have other distinct mechanisms beyond simple MOG-related immunopathology. 105, 107, 108 Optic nerve lesions MRI abnormalities of the optic nerve have been found in 44-83% of patients. 102, 109, 111 Bilateral, longitudinally extensive, symmetrical optic neuritis in the intraorbital segments is characteristic. 97, 102, 112, 113 An edematous appearance of the involved optic nerves and gadolinium enhancement Figure 14 Non-longitudinally extensive myelitis in neuromyelitis optica spectrum disorder. Sagittal T2-weighted image shows a hyperintense lesion involving the upper cervical spinal cord and extending just one vertebral segment length (arrow). are often seen in the acute phase (Fig. 19) . 112 The optic chiasm is involved in 12% of patients, and the optic tract is involved in 2% of patients. 114 Peri-optic nerve enhancement (nerve sheath enhancement) is also often apparent. 102, 112, 114 Enhancement of the surrounding orbital fat might be identified. 102 Approximately 80% of patients experience ≥2 attacks of optic neuritis, although the majority of patients show significant recovery. 114 
Spinal cord lesions
Most spinal cord lesions present LETM (Fig. 20) , but non-longitudinally extensive myelitis is also sometimes seen. 102, 110 The central portion of the spinal cord on axial images is involved in 50-83% of patients. 97, 102, 110 The peripheral portion might also be involved. 102 The frequency of spinal cord abnormalities is reportedly variable (12-78%) . 97, 109, 111 This variety might be due to different patient selection criteria (if MOG-IgG testing is limited to patients with AQP4-IgG-negative NMOSD, the frequency of spinal cord lesion should be higher), patient ethnicity and/or different MRI scanning locations (i.e. some spinal cord lesions might be missed if the whole spinal cord is not scanned); further studies are required to confirm the frequency of spinal cord lesions among MOG encephalomyelitis patients who are diagnosed according to international preliminary criteria for the diagnosis of MOG encephalomyelitis or diagnostic criteria that might be established in the near future. According to earlier reports, lower portions of the spinal cord are more frequently involved than the upper spinal cord. 97, 110 However, a recent multiinstitutional study of 50 patients showed that the upper spinal cord is more frequently involved than the lower spinal cord. 102 Clues to differentiating between MS and other white matter lesions MS versus NMOSD MS patients are significantly more likely to have periventricular lesions than NMOSD patients, and NMOSD patients are more likely to have deep white matter lesions. 28, 115 Criteria of: (i) at least one lesion adjacent to the body of the lateral ventricle and in the inferior temporal lobe; (ii) presence of a subcortical U-fiber lesion; or (iii) a Dawson's finger-type lesion can distinguish MS from AQP4-positive NMOSD with 91% sensitivity and 87% specificity. 23 A recent multi-institutional study in Japan confirmed that periventricular white matter lesions, ovoid lesions, T1-black hole lesions, callosal-septal interface lesions and isolated U-fiber lesions are more frequently present in MS than in NMOSD. 28 Spinal cord lesions in NMOSD preferentially involve the central gray matter, whereas those in MS preferentially involve peripheral white matter, 116 although peripheral white matter is also sometimes involved in NMOSD. 117 The aforementioned multiinstitutional study also showed that more thoracic cord lesions are present in NMOSD than in MS, and that thoracic cord lesions are significantly longer than cervical cord lesions in NMOSD. 28 Of note, lesions involving the cervical spinal cord in NMOSD do not always represent LETM, and a significant number of lesions are non-longitudinally extensive myelitis (median length: 23 mm for cervical cord lesions; 63 mm for thoracic cord lesions; Fig. 14) . 28 
MS versus ADEM
MRI appearances of ADEM and MS in pediatric patients are often similar, so differentiating between these diseases is not straightforward. 118 Callen et al. 89 proposed criteria (Callen MS-ADEM criteria) to distinguish MS from ADEM in children. In these criteria, MS is to be distinguished from ADEM by any two of: (i) absence of a diffuse bilateral lesion pattern; (ii) presence of black holes; and (iii) presence of two or more periventricular lesions. These are currently considered the most useful criteria, offering relatively high sensitivity and specificity. 119 
MS lesions versus non-specific white matter lesions
Misdiagnosis of MS remains a matter of concern. 35, 120 Rates of misdiagnosis have been reported to be up to 10%. 121 The most common lesions that can be misdiagnosed as MS are non-specific white matter Figure 20 Spinal cord lesion in myelin oligodendrocyte glycoprotein encephalomyelitis. Sagittal T2-weighted shows extensive hyperintensity (longitudinally extensive transverse myelitis) involving the cervical spinal cord. Mild cord swelling is also seen. lesions. 122 Red flags for MRI diagnosis for MS are listed in Table 1 , which could be useful for distinguishing MS lesions from non-specific white matter lesions. 36 
Conclusions
The present review provides an update of characteristic lesions for major demyelinating diseases, as well as clues to differentiating between MS and other demyelinating diseases, which might be helpful for differential diagnoses.
